297 related articles for article (PubMed ID: 24098750)
1. Recombinant thrombomodulin protects mice against histone-induced lethal thromboembolism.
Nakahara M; Ito T; Kawahara K; Yamamoto M; Nagasato T; Shrestha B; Yamada S; Miyauchi T; Higuchi K; Takenaka T; Yasuda T; Matsunaga A; Kakihana Y; Hashiguchi T; Kanmura Y; Maruyama I
PLoS One; 2013; 8(9):e75961. PubMed ID: 24098750
[TBL] [Abstract][Full Text] [Related]
2. Effect of Recombinant Human Soluble Thrombomodulin on Coagulation-Related Variables in Patients With Sepsis-Induced Disseminated Intravascular Coagulation: A Retrospective Observational Study.
Mitaka C; Kawagoe I; Satoh D; Hayashida M
Clin Appl Thromb Hemost; 2021; 27():10760296211050356. PubMed ID: 34859680
[TBL] [Abstract][Full Text] [Related]
3. Recombinant Thrombomodulin Suppresses Histone-Induced Neutrophil Extracellular Trap Formation.
Shrestha B; Ito T; Kakuuchi M; Totoki T; Nagasato T; Yamamoto M; Maruyama I
Front Immunol; 2019; 10():2535. PubMed ID: 31736962
[TBL] [Abstract][Full Text] [Related]
4. Comparison of recombinant human thrombomodulin and gabexate mesylate for treatment of disseminated intravascular coagulation (DIC) with sepsis following emergent gastrointestinal surgery: a retrospective study.
Akahoshi T; Sugimori H; Kaku N; Tokuda K; Nagata T; Noda E; Morita M; Hashizume M; Maehara Y
Eur J Trauma Emerg Surg; 2015 Oct; 41(5):531-8. PubMed ID: 26038004
[TBL] [Abstract][Full Text] [Related]
5. Multicenter clinical experience with recombinant soluble thrombomodulin for disseminated intravascular coagulation associated with severe acute cholecystitis.
Ogura T; Eguchi T; Amano M; Sano T; Nishioka N; Miyano A; Tsujimae M; Tanimura H; Yamada T; Terashima Y; Okada A; Higuchi K
Thromb Res; 2019 Apr; 176():74-78. PubMed ID: 30780007
[TBL] [Abstract][Full Text] [Related]
6. Efficacy of recombinant human soluble thrombomodulin in patients with sepsis and disseminated intravascular coagulation in the gastroenterology field.
Ito T; Nagahara A; Osada T; Kato J; Ueyama H; Saito H; Taniki N; Kanazawa R; Shimizu R; Sai J; Shiina S; Watanabe S
Biomed Rep; 2015 Jul; 3(4):457-460. PubMed ID: 26171148
[TBL] [Abstract][Full Text] [Related]
7. Successful treatment of disseminated intravascular coagulation by recombinant human soluble thrombomodulin in patients with acute myeloid leukemia.
Ookura M; Hosono N; Tasaki T; Oiwa K; Fujita K; Ito K; Lee S; Matsuda Y; Morita M; Tai K; Negoro E; Kishi S; Iwasaki H; Ueda T; Yamauchi T
Medicine (Baltimore); 2018 Nov; 97(44):e12981. PubMed ID: 30383650
[TBL] [Abstract][Full Text] [Related]
8. Thrombin generation mediators and markers in sepsis-associated coagulopathy and their modulation by recombinant thrombomodulin.
Hoppensteadt D; Tsuruta K; Cunanan J; Hirman J; Kaul I; Osawa Y; Fareed J
Clin Appl Thromb Hemost; 2014 Mar; 20(2):129-35. PubMed ID: 23804232
[TBL] [Abstract][Full Text] [Related]
9. Thrombomodulin as a Physiological Modulator of Intravascular Injury.
Watanabe-Kusunoki K; Nakazawa D; Ishizu A; Atsumi T
Front Immunol; 2020; 11():575890. PubMed ID: 33042158
[TBL] [Abstract][Full Text] [Related]
10. [Efficacy of Recombinant Thrombomodulin for Sepsis-Associated Disseminated Intravascular Coagulation Caused by Urinary Tract Infections].
Tachibana A; Iida K; Itami Y; Hashimura M; Toyoshima Y; Hosokawa Y; Fujimoto K
Hinyokika Kiyo; 2023 Nov; 69(11):309-314. PubMed ID: 38031329
[TBL] [Abstract][Full Text] [Related]
11. Successful treatment of sepsis-induced disseminated intravascular coagulation in a patient with idiopathic thrombocytopenic purpura using recombinant human soluble thrombomodulin.
Koga T; Inoue D; Okada A; Aramaki T; Yamasaki S; Nakashima M; Kawakami A; Eguchi K
Rheumatol Int; 2011 Dec; 31(12):1657-9. PubMed ID: 21240494
[TBL] [Abstract][Full Text] [Related]
12. Effective combination therapy of polymyxin-B direct hemoperfusion and recombinant thrombomodulin for septic shock accompanied by disseminated intravascular coagulation: a historical controlled trial.
Yamato M; Minematsu Y; Fujii J; Mori K; Minato T; Miyagawa S; Fujimura R; Morikage N; Arata Y; Nakano C; Wada A; Ito T
Ther Apher Dial; 2013 Oct; 17(5):472-6. PubMed ID: 24107274
[TBL] [Abstract][Full Text] [Related]
13. Retrospective analysis on the clinical outcomes of recombinant human soluble thrombomodulin for disseminated intravascular coagulation syndrome associated with solid tumors.
Ouchi K; Takahashi S; Chikamatsu S; Ito S; Takahashi Y; Kawai S; Okita A; Kasahara Y; Okada Y; Imai H; Komine K; Saijo K; Takahashi M; Shirota H; Takahashi M; Gamoh M; Ishioka C
Int J Clin Oncol; 2018 Aug; 23(4):790-798. PubMed ID: 29511940
[TBL] [Abstract][Full Text] [Related]
14. Clinical Impact of Recombinant Soluble Thrombomodulin for Disseminated Intravascular Coagulation Associated with Severe Acute Cholangitis.
Okuda A; Ogura T; Imanishi M; Miyano A; Nishioka N; Higuchi K
Gut Liver; 2018 Jul; 12(4):471-477. PubMed ID: 29699063
[TBL] [Abstract][Full Text] [Related]
15. [The role of thrombomodulin in sepsis-associated DIC].
Ito T
Rinsho Ketsueki; 2016 Apr; 57(4):405-11. PubMed ID: 27169442
[TBL] [Abstract][Full Text] [Related]
16. Efficacy and Bleeding Risk of Antithrombin Supplementation in Patients With Septic Disseminated Intravascular Coagulation: A Third Survey.
Iba T; Gando S; Saitoh D; Ikeda T; Anan H; Oda S; Kitamura N; Mori S; Kotani J; Kuroda Y
Clin Appl Thromb Hemost; 2017 Jul; 23(5):422-428. PubMed ID: 27161759
[TBL] [Abstract][Full Text] [Related]
17. Recombinant human thrombomodulin for pneumonia-induced severe ARDS complicated by DIC in children: a preliminary study.
Hirata N; Ngo DT; Phan PH; Ainai A; Phung TTB; Ta TA; Takasaki J; Kawachi S; Nunoi H; Nakajima N; Dien TM
J Anesth; 2021 Oct; 35(5):638-645. PubMed ID: 34259911
[TBL] [Abstract][Full Text] [Related]
18. Factors influencing the effectiveness of recombinant human soluble thrombomodulin on disseminated intravascular coagulation: a retrospective study.
Asai Y; Yamamoto T; Kito D; Ichikawa K; Abe Y
J Pharm Health Care Sci; 2020 Dec; 6(1):26. PubMed ID: 33292809
[TBL] [Abstract][Full Text] [Related]
19. Thrombomodulin in the management of acute cholangitis-induced disseminated intravascular coagulation.
Suetani K; Okuse C; Nakahara K; Michikawa Y; Noguchi Y; Suzuki M; Morita R; Sato N; Kato M; Itoh F
World J Gastroenterol; 2015 Jan; 21(2):533-40. PubMed ID: 25593469
[TBL] [Abstract][Full Text] [Related]
20. Recombinant human soluble thrombomodulin is associated with attenuation of sepsis-induced renal impairment by inhibition of extracellular histone release.
Akatsuka M; Masuda Y; Tatsumi H; Yamakage M
PLoS One; 2020; 15(1):e0228093. PubMed ID: 31971961
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
